MX342946B - Derivados de trisacaridos, y su uso como adyuvantes. - Google Patents

Derivados de trisacaridos, y su uso como adyuvantes.

Info

Publication number
MX342946B
MX342946B MX2012014422A MX2012014422A MX342946B MX 342946 B MX342946 B MX 342946B MX 2012014422 A MX2012014422 A MX 2012014422A MX 2012014422 A MX2012014422 A MX 2012014422A MX 342946 B MX342946 B MX 342946B
Authority
MX
Mexico
Prior art keywords
trisaccharide
adjuvants
derivatives
trisaccharides
adjuvant compositions
Prior art date
Application number
MX2012014422A
Other languages
English (en)
Spanish (es)
Other versions
MX2012014422A (es
Inventor
Patrick Hof Robert
Gernardus Mathias Marie Van Bree Johannes
Joannes Peter Maria Schenkelaars Everardus
Anne Turkstra Jouwert
Aldegonda Jacoba Kriek Maria
Martinus Maria Schaaper Wilhelmus
Original Assignee
Immunovo B V *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B V * filed Critical Immunovo B V *
Publication of MX2012014422A publication Critical patent/MX2012014422A/es
Publication of MX342946B publication Critical patent/MX342946B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
MX2012014422A 2010-06-11 2011-06-03 Derivados de trisacaridos, y su uso como adyuvantes. MX342946B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (2)

Publication Number Publication Date
MX2012014422A MX2012014422A (es) 2013-08-27
MX342946B true MX342946B (es) 2016-10-18

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014422A MX342946B (es) 2010-06-11 2011-06-03 Derivados de trisacaridos, y su uso como adyuvantes.

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR102922337B1 (ko) 2023-10-11 2026-02-05 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
DE602005010101D1 (de) * 2005-12-01 2008-11-13 Wella Ag Verwendung von Di- oder Oligosaccharidepolyestern in Haarstylingprodukten
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
US8993536B2 (en) * 2009-02-02 2015-03-31 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
IL223570A (en) 2017-03-30
JP2016216471A (ja) 2016-12-22
JP6004586B2 (ja) 2016-10-12
DK2580226T3 (en) 2018-01-08
CA2802023C (en) 2020-07-14
CA2802023A1 (en) 2011-12-15
RU2013100945A (ru) 2014-07-20
BR112012031440A2 (pt) 2017-04-18
RS56690B1 (sr) 2018-03-30
SMT201700603T1 (it) 2018-03-08
EP2580226B1 (en) 2017-11-29
HRP20171947T1 (hr) 2018-02-23
NO2580226T3 (enExample) 2018-04-28
US20130273082A1 (en) 2013-10-17
MX2012014422A (es) 2013-08-27
LT2580226T (lt) 2018-02-26
HUE035187T2 (hu) 2018-05-02
WO2011155822A1 (en) 2011-12-15
PL2580226T3 (pl) 2018-05-30
US20170057987A1 (en) 2017-03-02
EP2580226A1 (en) 2013-04-17
KR20130056273A (ko) 2013-05-29
JP2013528211A (ja) 2013-07-08
EP3312188A1 (en) 2018-04-25
ES2654156T3 (es) 2018-02-12
AU2011262606B2 (en) 2016-10-27
CY1119704T1 (el) 2018-06-27
US9327020B2 (en) 2016-05-03
CN103154013A (zh) 2013-06-12
EP2397484A1 (en) 2011-12-21
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
KR101929973B1 (ko) 2018-12-18
ZA201209395B (en) 2014-05-28
RU2595717C2 (ru) 2016-08-27
CN103154013B (zh) 2017-03-15
PT2580226T (pt) 2018-01-05

Similar Documents

Publication Publication Date Title
CU24272B1 (es) Derivados de tetrahidropirido-pirimidina como inhibidores de mek
NI201400005A (es) Indazoles
MX385408B (es) Microorganismos que producen ácido eicosapentaenoico, composiciones de ácidos grasos, y métodos para prepararlos y usos de los mismos.
ECSP14004812A (es) Triazolopiridinas sustituidas
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
EA201291154A1 (ru) Выбор дозы синтетических наноносителей с адъювантами
MX347573B (es) Composiciones y metodos para incrementar la estabilidad de aditivos para productos alimenticios.
BR112014018032A2 (pt) método para produzir uma composição
UY35046A (es) Cepa muscodor albus que produce compuestos orgánicos volátiles y métodos de uso
ECSP12012031A (es) Composición farmacéutica que comprende oligopéptidos
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
AR087254A1 (es) Gliceratos de metales alcalinos y alcalinoterreos para la desacidificacion y secado de esteres de acidos grasos
MX362752B (es) Formas mórficas de ésteres de hexadeciloxipropil-fosfonato.
CR20140124A (es) Metabolitos de transclomifeno y usos de los mismos
CL2013003093A1 (es) Composiciones que comprende cation de polihidroxioxoaluminio detectable por rmn; metodo de fabricacion de los mismos; y su uso.
CL2017001588A1 (es) Ácidos piridil-cicloalquil-carboxílicos sustituidos, composiciones que los contienen y usos de los mismos
BR112016030294A2 (pt) Cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas
UY33528A (es) Derivados de oxadiazoles y de piridazinas, su preparacion y su aplicacion en terapeutica
CR20120592A (es) Intermedios de agomelatina y métodos de preparación de estos
PL2794549T3 (pl) Kompozycje estrów kwasów tłuszczowych do wykorzystania jako środki zmiękczające
CR20110251A (es) Metodo para la obtencion de un extracto rico en taninos del acido elágico a partir de frutos que contiednen estos compuestos y extracto obtenido usando dicho metodo.
MX2012014422A (es) Derivados de trisacaridos, y su uso como adyuvantes.
BR112014013906A2 (pt) ésteres de fosfato aromáticos como componentes de formulação agroquímica
IN2015DN00085A (enExample)
CU24311B1 (es) Método de preparación de compuestos alfa-galactosil ceramidas

Legal Events

Date Code Title Description
FG Grant or registration